Challenges in the clinical translation of exosomal therapy in regenerative medicine

References

• 1. Fisher MB, Mauck RL. Tissue engineering and regenerative medicine: recent innovations and the transition to translation. Tissue Eng. Part B Rev. 19(1), 1–13 (2013).
  Medline CASGoogle Scholar
• 2. Atala A. Tissue engineering and regenerative medicine: concepts for clinical application. Rejuvenation Res. 7(1), 15–31 (2004).
  MedlineGoogle Scholar
• 3. Furth ME, Atala A, Van Dyke ME. Smart biomaterials design for tissue engineering and regenerative medicine. Biomaterials 28(34), 5068–5073 (2007).
  Medline CASGoogle Scholar
• 4. Pina S, Ribeiro VP, Marques CF et al. Scaffolding strategies for tissue engineering and regenerative medicine applications. Materials 12(11), 1824 (2019).
  CASGoogle Scholar
• 5. Muthu S, Bapat A, Jain R, Jeyaraman N, Jeyaraman M. Exosomal therapy-a new frontier in regenerative medicine. Stem Cell Investig. 8, 7 (2021).
  Medline CASGoogle Scholar
• 6. Banerjee A, Jain SM, S Abrar S, Kumar MM, Mathew C, Pathak S. Sources, isolation strategies and therapeutic outcome of exosomes at a glance. Regen. Med. 15(12), 2361–2378 (2020).
  CASGoogle Scholar
• 7. Liang B, He X, Zhao Y-X, Zhang X-X, Gu N. Advances in exosomes derived from different cell sources and cardiovascular diseases. BioMed Res. Intl 2020, e7298687 (2020).
  MedlineGoogle Scholar
• 8. Akuma P, Okagu OD, Udenigwe CC. Naturally occurring exosome vesicles as potential delivery vehicle for bioactive compounds. Front. Sustain. Food Syst. 3, 23 (2019).
  Google Scholar
• 9. Börger V, Weiss DJ, Anderson JD et al. International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19. Cytotherapy 22(9), 482–485 (2020).
  MedlineGoogle Scholar
• 10. Wang J, Chen D, Ho EA. Challenges in the development and establishment of exosome-based drug delivery systems. J. Control. Rel. 329, 894–906 (2021).
  Medline CASGoogle Scholar
• 11. Chen Y-S, Lin E-Y, Chiou T-W, Harn H-J. Exosomes in clinical trial and their production in compliance with good manufacturing practice. Tzu Chi Med. J. 32(2), 113–120 (2019).
  Google Scholar
• 12. Gardiner C, Di Vizio D, Sahoo S et al. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J. Extracell. Vesicles 5, 32945 (2016).
  MedlineGoogle Scholar
• 13. Tauro BJ, Greening DW, Mathias RA et al. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods 56(2), 293–304 (2012).
  Medline CASGoogle Scholar
• 14. Van Deun J, Mestdagh P, Sormunen R et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J. Extracell. Vesicles 3(1), 24858 (2014).
  Google Scholar
• 15. Riau AK, Ong HS, Yam GHF, Mehta JS. Sustained delivery system for stem cell-derived exosomes. Front Pharmacol. 10, 1368 (2019).
  Medline CASGoogle Scholar
• 16. Patel DB, Gray KM, Santharam Y, Lamichhane TN, Stroka KM, Jay SM. Impact of cell culture parameters on production and vascularization bioactivity of mesenchymal stem cell‐derived extracellular vesicles. Bioeng. Transl. Med. 2(2), 170–179 (2017).
  Medline CASGoogle Scholar
• 17. Meng W, He C, Hao Y, Wang L, Li L, Zhu G. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source. Drug Deliv. 27(1), 585–598 (2020).
  Medline CASGoogle Scholar
• 18. Elliott RO, He M. Unlocking the power of exosomes for crossing biological barriers in drug delivery. Pharmaceutics 13(1), 122 (2021).
  MedlineGoogle Scholar
• 19. Gutiérrez-Vázquez C, Villarroya-Beltri C, Mittelbrunn M, Sánchez-Madrid F. Transfer of extracellular vesicles during immune cell-cell interactions. Immunol. Rev. 251(1), 125–142 (2013).
  MedlineGoogle Scholar
• 20. Prunevieille A, Babiker-Mohamed MH, Aslami C, Gonzalez-Nolasco B, Mooney N, Benichou G. T cell antigenicity and immunogenicity of allogeneic exosomes. Am. J. Transpl. 21(7), 2583–2589 (2021).
  Medline CASGoogle Scholar
• 21. Fuhrmann G, Serio A, Mazo M, Nair R, Stevens MM. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J. Control. Rel. 205, 35–44 (2015).
  Medline CASGoogle Scholar
• 22. Mendt M, Kamerkar S, Sugimoto H et al. Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight 3(8), 99263 (2018).
  MedlineGoogle Scholar
• 23. Jeyaram A, Jay SM. Preservation and storage stability of extracellular vesicles for therapeutic applications. AAPS J. 20(1), 1 (2017).
  MedlineGoogle Scholar
• 24. Rezabakhsh A, Sokullu E, Rahbarghazi R. Applications, challenges and prospects of mesenchymal stem cell exosomes in regenerative medicine. Stem Cell Res. Ther. 12(1), 521 (2021).
  Medline CASGoogle Scholar
• 25. Kusuma GD, Barabadi M, Tan JL, Morton DAV, Frith JE, Lim R. To protect and to preserve: novel preservation strategies for extracellular vesicles. Front Pharmacol. 9, 1199 (2018).
  Medline CASGoogle Scholar
• 26. Xu M, Feng T, Liu B et al. Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies. Theranostics 11(18), 8926–8944 (2021).
  Medline CASGoogle Scholar
• 27. Luan X, Sansanaphongpricha K, Myers I, Chen H, Yuan H, Sun D. Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol. Sin. 38(6), 754–763 (2017).
  Medline CASGoogle Scholar